Bionano Genomics Inc. (BNGO)
4.82
0.30 (6.64%)
At close: Apr 14, 2025, 3:59 PM
4.78
-0.74%
After-hours: Apr 14, 2025, 07:59 PM EDT
6.64% (1D)
| Bid | 4.74 |
| Market Cap | 14.49M |
| Revenue (ttm) | 30.78M |
| Net Income (ttm) | -112.02M |
| EPS (ttm) | -88.13 |
| PE Ratio (ttm) | -0.05 |
| Forward PE | -0.18 |
| Analyst | Hold |
| Ask | 4.85 |
| Volume | 374,457 |
| Avg. Volume (20D) | 199,279 |
| Open | 4.70 |
| Previous Close | 4.52 |
| Day's Range | 4.53 - 5.21 |
| 52-Week Range | 2.68 - 72.60 |
| Beta | 2.09 |
About BNGO
Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents ...
Industry Medical - Diagnostics & Research
Sector Healthcare
IPO Date Aug 21, 2018
Employees 98
Stock Exchange NASDAQ
Ticker Symbol BNGO
Website https://www.bionanogenomics.com
Analyst Forecast
According to 4 analyst ratings, the average rating for BNGO stock is "Hold." The 12-month stock price forecast is $7, which is an increase of 45.23% from the latest price.
Stock ForecastsNext Earnings Release
Bionano Genomics Inc. is scheduled to release its earnings on May 7, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
+20.97%
Bionano Genomics shares are trading higher after S...
Unlock content with
Pro Subscription
2 months ago
-28.66%
Bionano Genomics shares are trading lower after the company announced a 1-for-60 reverse stock split.
